Steve Smith

839 total citations
9 papers, 600 citations indexed

About

Steve Smith is a scholar working on Genetics, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Steve Smith has authored 9 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 2 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Steve Smith's work include Kruppel-like factors research (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Photodynamic Therapy Research Studies (1 paper). Steve Smith is often cited by papers focused on Kruppel-like factors research (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Photodynamic Therapy Research Studies (1 paper). Steve Smith collaborates with scholars based in United Kingdom and United States. Steve Smith's co-authors include Clare East, D. Bareford, Claire Harrison, Peter J. Campbell, Mike Scott, Linda M. Scott, Donald Milligan, Bridget S. Wilkins, Keith Wheatley and Elaine Boyd and has published in prestigious journals such as The Lancet, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Steve Smith

8 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steve Smith United Kingdom	6	468	353	258	226	74	9	600
Etsuko Aoki United States	8	86 0.2×	174 0.5×	136 0.5×	29 0.1×	14 0.2×	16	364
M. Q. Lacy United States	7	79 0.2×	428 1.2×	189 0.7×	35 0.2×	33 0.4×	11	554
Amine Belhabri France	14	112 0.2×	147 0.4×	272 1.1×	29 0.1×	26 0.4×	40	458
Loretta Pfannes United States	9	81 0.2×	125 0.4×	229 0.9×	15 0.1×	10 0.1×	19	373
Sayoko Doisaki Japan	12	98 0.2×	117 0.3×	182 0.7×	24 0.1×	39 0.5×	28	387
Angela Martin United States	6	84 0.2×	50 0.1×	106 0.4×	33 0.1×	10 0.1×	10	366
Silvia Manfroi Italy	13	96 0.2×	167 0.5×	302 1.2×	15 0.1×	22 0.3×	34	491
Srinivas Aluri United States	8	55 0.1×	142 0.4×	65 0.3×	79 0.3×	11 0.1×	30	291
S. Murphy United States	8	129 0.3×	80 0.2×	121 0.5×	48 0.2×	5 0.1×	13	341
Norzawani B Buang United Kingdom	5	24 0.1×	116 0.3×	46 0.2×	77 0.3×	33 0.4×	5	360

Countries citing papers authored by Steve Smith

Since Specialization

Citations

This map shows the geographic impact of Steve Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Smith more than expected).

Fields of papers citing papers by Steve Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Smith. The network helps show where Steve Smith may publish in the future.

Co-authorship network of co-authors of Steve Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Smith. A scholar is included among the top collaborators of Steve Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Smith. Steve Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Smith, Steve, et al.. (2023). BI19 Cutaneous post-transplant lymphoproliferative disorder in an immunosuppressed patient. British Journal of Dermatology. 188(Supplement_4).

2.

James, Kenneth D., et al.. (2016). CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility. The Journal of Antibiotics. 70(2). 130–135. 77 indexed citations

3.

Campbell, Peter J., Linda M. Scott, Georgina Buck, et al.. (2005). Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. The Lancet. 366(9501). 1945–1953. 473 indexed citations

4.

Green, Anthony R., Peter J. Campbell, Linda M. Scott, et al.. (2005). JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera.. Blood. 106(11). 253–253. 6 indexed citations

5.

Robinson, Heather & Steve Smith. (2004). Mycobacterium fortuitum infection in a patient with chronic lymphocytic leukaemia. British Journal of Haematology. 127(2). 126–126. 4 indexed citations

6.

Smith, Steve, et al.. (2000). Systemic non-Hodgkin's lymphoma presenting as a serpiginous choroidopathy: Report of a case and review of the literature. Eye. 14(5). 706–710. 18 indexed citations

7.

Smith, Steve, et al.. (1992). Actions of a 5-lipoxygenase inhibitor, Sch 40120, on acute inflammatory responses.. Journal of Pharmacology and Experimental Therapeutics. 262(2). 721–728. 7 indexed citations

8.

Smith, Steve, et al.. (1989). Cationic Triarylmethane Photosensitizers For Selective Photochemotherapy: Victoria Blue-Bo, Victoria Blue-R And Malachite Green. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 997. 154–154. 14 indexed citations

9.

Kreutner, William, et al.. (1988). 590 Inhibition of leukotriene formation by sch 37224, a new antiallergy agent with anti-inflammatory activity. Journal of Allergy and Clinical Immunology. 81(1). 315–315. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact